Abstract
Under the newly passed Leahy-Smith America Invents Act (AIA), the U.S. Patent and Trademark Office may hear new challenges to stem cell patents. Here, we explore how the new law affects challenges to stem cell patents, focusing on two recent cases, and discuss the future of stem cell patent disputes.
Original language | English (US) |
---|---|
Pages (from-to) | 461-464 |
Number of pages | 4 |
Journal | Cell Stem Cell |
Volume | 16 |
Issue number | 5 |
DOIs |
|
State | Published - May 7 2015 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Genetics
- Cell Biology